Utah Expands Artificial Intelligence Healthcare Pilots

The state is scaling its medical AI testing sandbox while requiring new independent technical evaluations for all participants.

Updated on Oct. 21, 2026 in Artificial Intelligence

Bold flat-color editorial illustration of a geometric diagnostic aperture, representing the rigorous evaluation of medical artificial intelligence in Utah.
Utah has expanded its medical AI regulatory sandbox to include three new pilot programs, requiring independent evaluations for all participants. AI Illustration. Upload story photo >

Live Poll

Should technology companies be held directly liable for medical errors caused by their AI systems?

Utah has expanded its artificial intelligence regulatory sandbox to include three new healthcare pilot programs. These initiatives allow companies to test medical technologies under state supervision while the state refines its legal and clinical oversight frameworks.

Why it matters

The move aims to establish a formal statutory framework for AI liability in medicine following internal friction regarding clinical oversight. This expansion marks a shift toward more rigorous state-led evaluation of medical AI tools before they reach broader adoption.

The state has tapped six independent organizations to serve as external evaluators for technical claims. Participating companies are required to maintain special liability insurance, a mandate introduced after scrutiny of prior automated refill tests.

The players

Utah Medical Licensing Board

The state regulatory authority responsible for physician licensing and oversight of medical pilot operations.

Doctronic

A technology company specializing in AI-assisted prescription refill workflows.

Intermountain Health

A regional healthcare provider holding agreements with the state regarding potential AI pilot proposals.

University of Utah Health

An academic medical center engaged in potential partnerships for AI-integrated clinical pilot programs.

The details

The sandbox program functions as a controlled environment where firms test medical software under regulatory relief provided by the state. Future pilots must now contract with independent evaluators to verify performance claims, a change prompted by the Utah Medical Licensing Board. The board recently exerted more control over the program following a 2026 dispute involving AI-assisted prescription refills for drugs like butalbital.

Timeline

  1. 2024: Utah launched its artificial intelligence sandbox initiative.

  2. April 2026: The Utah Medical Licensing Board requested a pilot suspension.

  3. October 16, 2026: The state published reports confirming the program expansion.

The Tech Race

The expansion marks a transition from initial testing to a structured, multiyear effort to define AI liability in clinical settings. This approach places Utah among the few states attempting to codify regulatory oversight while simultaneously encouraging industry innovation.

Patients and healthcare providers in the state will see more scrutinized AI tools moving from development to supervised testing environments. These pilots effectively serve as a pre-market gate, requiring companies to carry insurance and pass technical audits before impacting clinical workflows.

The takeaway

The state is shifting toward a model that mandates third-party technical validation for all new healthcare pilots. Stakeholders should track the upcoming interim legislative session for new statutes that could define liability standards for automated medical tools.

What happens next

The state intends to introduce new legislation addressing AI-related liability during the upcoming interim legislative session.

Further reading

For broader trends in state-level oversight, see our Artificial Intelligence section.

Source note: This article includes information reported by PYMNTS.

Live Poll

Should technology companies be held directly liable for medical errors caused by their AI systems?